The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    CAM therapies should be subjected to more clinical research

    But can we afford the cost?

    Drs. Bertrand Graza and Jacques Falqueta from Antenna Technologie in Geneva, Switzerland, and Prof. Elaine Elisabetsky from the Universidade Federal do Rio Grande do Sul in Porto Alegre, Brazil believe we can, and here’s how.

    “Contrary to a commonly held myth,” the authors state that “clinical studies can be conducted at relatively low cost if one works with local/regional research institutes and with doctoral students, focusing on meaningful clinical measures rather than sophisticated laboratory analyses.”

    There are 3 types of studies that should be the focus of CAM research.

    • Retrospective trial: A study looking back in time, so the outcomes have occurred to the participants before the study commences. One example is called a case-control study.
    • Prognosis?outcome study: Patients with predetermined conditions are treated and, according to the authors, have modern physicians observing progress of patients treated by a traditional healer.
    • Dose?escalating prospective study: Study in humans (healthy or ill) in order to detect a relationship between the dose of a drug and the response to it.

    The bottom line?
    It’s suggested, “this approach offers the best cost-effective course of action for obtaining maximal benefits from traditional medicines, especially those used for treating endemic diseases.”

    9/13/07 20:29 JR

    Leave a Comment

    XHTML: Line-breaks are automatic. Available tags are <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>